Developing products for precision medicine: affordable, reliable, specific, quantifiable, and accurate precision diagnostic technology.
MultiplexDX is a biotech diagnostics company, developing accurate, specific, quantifiable, and affordable diagnostic tests. It aims to provide effective and successful treatment of tumors and prevent cancer. To achieve this, the company is in the phase of developing a new visualization technology combining the approach of molecular biology and histopathological methods. This technology has an ambition to surpass the limitations of existing medical diagnostic and prognostic methods and to take a key role in this fast-changing market.MultiplexDX operates from Kosice, Slovakia and Maryland, US and is currently serving first clients on both European and US markets.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Oct 4, 2018 | Series Unknown | €1.20M | 1 | — | — | Detail |
Oct 28, 2016 | Series Unknown | — | 1 | — | — | Detail |
Feb 1, 2016 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Neulogy Ventures | — | Series Unknown |